Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Nov 2008 for Altimmune, Inc., €1,899.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kevin Price: trading record in brief
One trade, one date: on 20 November 2008, Kevin Price disclosed an open-market purchase of €1,899 in Altimmune, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Price
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 2,500 shares@ US$0.95Common StockSEC:0001104659-08-072112:0Canonical exit: 17 Feb 2009 (T+90)
1 of 1 declaration
